Skip to main content
Back to News
RISA Labs secured 11.1 million USD in funding co-led by Cencora Ventures and Optum Ventures to scale...
Funding
1 min read
US

RISA Labs secured 11.1 million USD in funding co-led by Cencora Ventures and Optum Ventures to scale...

The AMW Read

The article reports a standard funding update for a player in the Vertical AI Healthcare segment, specifically focusing on oncology workflows.
NoveltySignificance
Healthcare & Bio Β· Player Map

RISA Labs secured 11.1 million USD in funding co-led by Cencora Ventures and Optum Ventures to scale its AI operating system for oncology. This investment highlights the rise of vertical AI agents that automate fragmented administrative and clinical workflows in cancer care. By streamlining coordination, the platform addresses systemic clinician burnout and treatment bottlenecks. Domain-specific AI infrastructure is now the standard for managing complex chronic care at scale. πŸš€πŸ₯

#AI #HealthTech #Oncology

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 4d agoInnovaccer acquires CaduceusHealth to expand AI-led revenue cycle managementInnovaccer
  2. 1w agoIsomorphic Labs raises $2.1B led by Thrive Capital in largest AI drug-discovery roundIsomorphic Labs
  3. 3w agoOpenAI model outperforms doctors in ER diagnoses, achieving 67% accuracy vs 55%OpenAI
  4. 1mo agoOpenAI Launches GPT-Rosalind, a Specialized Frontier Model for Life Sciences Research and Drug DiscoveryOpenAI
  5. 4mo agoRISA Labs secured 11.1 million USD in funding co-led by Cencora Ventures and Optum Ventures to scale... Β· THIS ARTICLE

Related News

More news from Risa Labs Inc.

Stay updated with the latest news and announcements from Risa Labs Inc..

View all Risa Labs Inc. news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard